基于网络药理学分析芪贞元丹治疗动脉粥样硬化的作用机制*

doi:10.12047/j.cjap.6230.2022.052

中国应用生理学杂志 ›› 2022, Vol. 38 ›› Issue (3): 273-278.doi: 10.12047/j.cjap.6230.2022.052

基于网络药理学分析芪贞元丹治疗动脉粥样硬化的作用机制^*

李林芳^1,2, 吕鑫钰³, 邱玉玲², 孔德新^2△

1.天津市天津医院药学部, 天津 300200;
2.天津医科大学药学院临床药学系, 天津 300070;
3.天津天狮学院医学院, 天津 301700

收稿日期:2021-12-10 修回日期:2022-05-24 出版日期:2022-05-28 发布日期:2022-09-05
通讯作者: ^△Tel: 022-83336659; E-mail: kongdexin@tmu.edu.cn
基金资助:
^*国家自然科学基金资助项目(82073890,81673464)

Potential molecular mechanisms of QiZhenYuanDan in treatment of atherosclerosis based on network pharmacology

LI Lin-fang^1,2, LYU Xin-yu³, QIU Yu-ling², KONG De-xin^2△

1. Department of Pharmacy, Tianjin Hospital, Tianjin 300200;
2. Department of Clinical Pharmacy, School of Pharmacy, Tianjin Medical University, Tianjin 300070;
3. School of Medicine, Tianjin Tianshi College, Tianjin 301700, China

Received:2021-12-10 Revised:2022-05-24 Online:2022-05-28 Published:2022-09-05

摘要/Abstract

摘要： 目的: 基于网络药理学方法,探究中药复方芪贞元丹治疗动脉粥样硬化(AS)潜在的作用靶点和分子机制。方法: 查找TCMSP数据库,获得中药复方芪贞元丹中黄芪、女贞子、延胡索、丹参的活性成分和靶点,在OMIM等数据库中检索AS的靶点,使用Cytoscape绘图工具构建分子网络;检索STRING数据库并绘制PPI网络图,获取芪贞元丹治疗AS的关键靶点;并上传至Metascape数据平台对其进行GO和KEGG分析。结果: 芪贞元丹与AS有交集靶点118个,作为干预AS的作用靶点。芪贞元丹对抗AS可能与细胞因子介导、细胞因子受体结合等GO过程相关。KEGG富集结果显示155条通路与AS相关,主要涉及PI3K-Akt、HIF-1、NF-κB通路和炎症性肠病相关通路。结论: 通过网络药理学实验初步揭示芪贞元丹复方治疗AS的作用机制,复方中的槲皮素、山奈酚等活性成分作用于IL-6、PI3K-Akt等靶点,通过抗细胞凋亡、抑制氧化应激、抑制炎症反应等发挥抗AS作用,证明芪贞元丹复方治疗AS是多成分、多靶点、多途径协同作用的过程。

关键词: 芪贞元丹, 网络药理学, 动脉粥样硬化, 槲皮素, 山奈酚, 白细胞介素-6, 磷脂酰肌醇3激酶/蛋白激酶B

Abstract: Objective: By means of network pharmacology, potential targets and molecular pathways of QiZhenYuanDan in the treatment of atherosclerosis (AS) were studied. Methods: TCMSP database was used to obtain the main active components and target information of Astragali Radix, Fructus Ligustri Lucidi, Corydalis Rhizoma and Salvia Miltiorrhiza in QiZhenYuanDan. Disease targets were retrieved by OMIM and other databases. Molecular networks were constructed using Cytoscape. STRING database was searched and PPI network diagram was drawn to obtain the key targets of QiZhenYuanDan in the treatment of AS; and the targets were uploaded to Metascape data platform for GO and KEGG analysis. Results: There were 118 targets of intersection between QiZhenYuanDan and AS, which were used as the predicted targets of QiZhenYuanDan on AS. GO analysis showed that the biological functions of QiZhenYuanDan in the treatment of AS targets mainly involved biological processes, such as the cytokine-mediated signaling pathway, cytokine receptor binding. KEGG pathway was mainly enriched in 155 signaling pathways, including PI3K-Akt, HIF-1, NF-κB signal pathway and inflammatory bowel disease pathway. Conclusion: Based on the result of network pharmacology study, the mechanisms of Qizhenyuandan for AS treatment was preliminarily revealed. The active ingredients such as quercetin and kaempferol act on targets such as IL-6 and PI3K-Akt, and exert anti-AS effects by inhibiting apoptosis, oxidative stress, as well as inflammatory responses. Our result indicates that QiZhenYuanDan exhibits anti-AS effect via a multi-component, multi-target and multi-route synergistic process.

Key words: QiZhenYuanDan, network pharmacology, atherosclerosis, quercetin, kaempferol, IL-6, PI3K-Akt

中图分类号:

R285.5

李林芳, 吕鑫钰, 邱玉玲, 孔德新. 基于网络药理学分析芪贞元丹治疗动脉粥样硬化的作用机制^*[J]. 中国应用生理学杂志, 2022, 38(3): 273-278.

LI Lin-fang, LYU Xin-yu, QIU Yu-ling, KONG De-xin. Potential molecular mechanisms of QiZhenYuanDan in treatment of atherosclerosis based on network pharmacology[J]. CJAP, 2022, 38(3): 273-278.

参考文献

[1] Zhou MG, Wang HD, Liang XF, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158.
[2] 赵艺涵, 赖润民, 史大卓, 等. 基于网络药理学探究川芎-黄连药对改善动脉粥样硬化的作用机制[J]. 中西医结合心脑血管病杂志, 2020, 18(11): 1677-1683.
[3] 罗微, 廖文璟, 罗庆, 等. 高迁移率族蛋白B1在动脉粥样硬化中的作用及其机制研究进展[J]. 国际检验医学杂志, 2020, 41(20): 2518-2521.
[4] 何信用, 王俊岩, 贾连群, 等. 浅谈从“心脾论治”防治冠心病[J]. 中医药导报, 2016, 22(16): 12-14.
[5] 陈图刚, 谭维羚, 马战清, 等. 黄芪注射液对外周血内皮祖细胞数量及功能的影响[J]. 中药新药与临床药理, 2007, 18(5): 364-368.
[6] 邱蓉丽, 李璘. 中药女贞子化学与药理研究进展[J]. 中药材, 2007, 30(7): 891-894.
[7] 李冰. 延胡索提取物抗大鼠血栓的实验研究[D]. 吉林: 长春中医药大学, 2014.
[8] 张发艳, 华声瑜, 范英昌. 丹酚酸B及丹参酮ⅡA对家兔动脉粥样硬化IL-8及VCAM-1的影响[J]. 山东中医药大学学报, 2006, 30(2): 152-154.
[9] 江颖娟, 蒋作锋, 吴小兰, 等. 槲皮素对TNF-α诱导内皮细胞炎症因子表达的影响[J]. 新医学, 2017, 48(10): 697-700.
[10] Huang CH, Jan RL, Kuo CH, et al. Natural flavone kaempferol suppresses chemokines expression in human monocyte THP-1 cells through MAPK pathways[J]. J Food Sci, 2010, 75(8): H254-H259.
[11] Kong LX, Luo C, Li XY, et al. The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits[J]. Lipids Health Dis, 2013, 12(1): 115.
[12] Nunes C, Almeida L, Barbosa RM, et al. Luteolin suppresses the JAK/ STAT pathway in a cellular model of intestinal inflammation[J]. Food Funct, 2017, 8(1): 387-396.
[13] 孙霁寒, 王兆丹, 孙桂菊, 等. 木犀草素对高血脂症SD大鼠肝脏脂肪变性及抗氧化水平的影响[J]. 食品工业科技, 2019, 40(11): 308-312.
[14] 肖亚莉, 黄鹤, 黄丹, 等. G蛋白信号调节因子5在动脉粥样硬化发展中的作用[J]. 医学研究杂志, 2016, 45(3): 178-180.
[15] Wilgus TA. Vascular endothelial growth factor and cutaneous scarring[J].Adv Wound Care, 2019, 8(12): 671-678.
[16] Chang H, Li X, Cai Q, et al. The PI3K/Akt/mTOR pathway is involved in CVB3-induced autophagy of HeLa cells[J]. Int J Mol Med, 2017, 40(1): 182-192.
[17] 姚血明, 马武开, 侯雷, 等. 重组人Ⅱ型TNF-α受体-抗体融合蛋白对胶原诱导性关节炎模型大鼠关节滑膜细胞NF-κB信号表达的影响[J]. 中国医院药学杂志, 2015, 35(22): 2005-2007.
[18] Yang FF, Sheng XM, Huang XX, et al. Interactions between Salmonella and host macrophages-Dissecting NF-κB signaling pathway responses[J]. Microb Pathog, 2021, 154: 104846.
[19] 陈灿, 刘江华, 祖旭宇, 等. 胰岛素信号通路与动脉粥样硬化[J]. 国际病理科学与临床杂志, 2013, 33(1): 62-66.
[20] 张西, 方珏敏, 陈依静, 等. 恶性肿瘤临终患者血浆D-二聚体动态检测回顾性分析[J]. 肿瘤防治研究, 2014, 41(4): 350-352.

基于网络药理学分析芪贞元丹治疗动脉粥样硬化的作用机制^*

Potential molecular mechanisms of QiZhenYuanDan in treatment of atherosclerosis based on network pharmacology

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

本文评价

[1]	陈启文, 吴国栋, 颜治云, 张文成, 张梅. 即早基因c-fos在THP-1单核巨噬细胞亚型极化中的差异表达^*[J]. 中国应用生理学杂志, 2020, 36(6): 534-538.
[2]	衣雪洁, 孙玉霞, 姚婷婷, 李晶, 高畅, 刘璐, 曹师承, 常波, 张翠萍. 急、慢性运动对2型糖尿病大鼠脂肪PI3K/AKT/GLUT4通路的影响[J]. 中国应用生理学杂志, 2020, 36(1): 12-16.
[3]	宋博雅, 郝选明. 运动干预对衰老模型大鼠血清炎性因子水平的影响[J]. 中国应用生理学杂志, 2020, 36(1): 42-44.
[4]	汪晨净, 裴淑燕, 南晓东, 马艳庆. 内皮素-1对大鼠血管平滑肌细胞产生MCP-1的影响及其机制[J]. 中国应用生理学杂志, 2018, 34(3): 283-288.
[5]	杜瑞雪, 叶平, 颜光涛, 邓子辉, 梁文涛, 郭子宽, 张红红, 耿淼. 瑞舒伐他汀对颈动脉粥样硬化患者单个核细胞CCR2表达的影响及机制[J]. 中国应用生理学杂志, 2016, 32(3): 202-206.
[6]	王敏, 刘善云, 张洪侠, 王亚慧, 刘凯. 耐力训练对ApoE^-/-致AS小鼠IL-18和IL-10表达的影响[J]. 中国应用生理学杂志, 2016, 32(3): 225-228.